These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1448427)

  • 1. Dose proportionality of transdermal nitroglycerin.
    Jewell RC; Banfield CR; Ruggirello DA; Huang YW; Noonan PK; Gonzalez MA
    Pharm Res; 1992 Oct; 9(10):1284-9. PubMed ID: 1448427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of nitroglycerin and its dinitrate metabolites over a thirtyfold range of oral doses.
    Nakashima E; Rigod JF; Lin ET; Benet LZ
    Clin Pharmacol Ther; 1990 May; 47(5):592-8. PubMed ID: 2111749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of glyceryl trinitrate and its dinitrate metabolites after sublingual administration to volunteers. Simultaneous determination of glyceryl trinitrate and its dinitrate metabolites.
    Jensen KM; Dahl JB
    Arzneimittelforschung; 1994 Aug; 44(8):951-3. PubMed ID: 7945539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence evaluation of the metabolites 1,2 and 1,3-glyceryl dinitrate of two different glyceryl trinitrate patches after 12-h usage in healthy volunteers.
    Hutt V; Sauter K; Pabst G; Bonn R; Fritschi E
    Arzneimittelforschung; 1994 Dec; 44(12):1317-21. PubMed ID: 7848350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitroglycerin absorption from transdermal systems: formulation effects and metabolite concentrations.
    Williams RL; Thakker KM; John V; Lin ET; Liang-Gee W; Benet LZ
    Pharm Res; 1991 Jun; 8(6):744-9. PubMed ID: 1905809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics and bioavailability of nitroglycerin and its metabolites from Transderm-Nitro, Nitrodisc, and Nitro-Dur II systems using a stable-isotope technique.
    Sun JX; Piraino AJ; Morgan JM; Joshi JC; Cipriano A; Chan K; Redalieu E
    J Clin Pharmacol; 1995 Apr; 35(4):390-7. PubMed ID: 7650229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability and pharmacokinetic profile of glyceryl trinitrate and of glyceryl dinitrates during application of a new glyceryl trinitrate transdermal patch.
    Santoro A; Rovati LC; Setnikar I; Caplain H; Gualano V
    Arzneimittelforschung; 2000 Sep; 50(9):779-85. PubMed ID: 11050693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of glyceryl trinitrate and dinitrates during application of three strengths of a new glyceryl trinitrate transdermal patch.
    Santoro A; Rovati LC; Follet M; Setnikar I; Caplain H; Gualano V
    Arzneimittelforschung; 2000 Sep; 50(9):786-94. PubMed ID: 11050694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable glyceryl dinitrate formation as a function of route of nitroglycerin administration.
    Noonan PK; Benet LZ
    Clin Pharmacol Ther; 1987 Sep; 42(3):273-7. PubMed ID: 3113806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroglycerin dinitrate metabolites do not affect the pharmacokinetics and pharmacodynamics of nitroglycerin in the dog: a preliminary report.
    Lee FW; Hu J; Metzler CH; Benet LZ
    J Pharmacokinet Biopharm; 1993 Apr; 21(2):163-73. PubMed ID: 8229678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue disposition of glyceryl trinitrate, 1,2-glyceryl dinitrate, and 1,3-glyceryl dinitrate in tolerant and nontolerant rats.
    Torfgård KE; Ahlner J; Axelsson KL; Norlander B; Bertler A
    Drug Metab Dispos; 1992; 20(4):553-8. PubMed ID: 1356734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance development and arterial and venous tissue-/plasma levels of glyceryl trinitrate and glyceryl dinitrate in patients treated with nitroglycerin infusion.
    Torfgård KE; Svedjeholm R; Håkansson E; Ahlner J
    Arzneimittelforschung; 1995 Sep; 45(9):963-6. PubMed ID: 7488313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic and pharmacokinetic evaluation of a new transdermal delivery system with a time-dependent release of glyceryl trinitrate.
    Wiegand A; Bauer KH; Bonn R; Trenk D; Jähnchen E
    J Clin Pharmacol; 1992 Jan; 32(1):77-84. PubMed ID: 1740541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal bioavailability and first-pass skin metabolism: a preliminary evaluation with nitroglycerin.
    Nakashima E; Noonan PK; Benet LZ
    J Pharmacokinet Biopharm; 1987 Aug; 15(4):423-37. PubMed ID: 3119815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of organic nitrates in man: an overview.
    Bogaert MG
    Eur Heart J; 1988 Jan; 9 Suppl A():33-7. PubMed ID: 3137070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its two dinitrate metabolites in conscious dogs.
    Lee FW; Salmonson T; Metzler CH; Benet LZ
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1222-9. PubMed ID: 2124621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pattern of glyceryl nitrates after oral administration of glyceryl trinitrate.
    Laufen H; Leitold M
    Arzneimittelforschung; 1988 Jan; 38(1):103-5. PubMed ID: 3130064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the two dinitrate metabolites of nitroglycerin in human plasma by capillary gas chromatography with electron-capture detection.
    Sioufi A; Pommier F; Dubois JP
    J Chromatogr; 1987 Jan; 413():101-8. PubMed ID: 3104382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of nitroglycerin and metabolites in humans following oral dosing.
    Yu DK; Williams RL; Benet LZ; Lin ET; Giesing DH
    Biopharm Drug Dispos; 1988; 9(6):557-65. PubMed ID: 3147725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human maternal and fetal plasma glyceryl trinitrate concentrations.
    Bustard MA; Ryan G; Seaward G; Saleniak ME; Smith GN
    Am J Obstet Gynecol; 2003 Dec; 189(6):1777-8. PubMed ID: 14710114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.